English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NA /

2021-0512

Clinical Efficacy And Mechanisms Of Resistance To Polatuzumab Vedotin In Patients With Large B-Cell Lymphoma After CAR T-Cell Therapy

DISEASE GROUP:
Lymphoma
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: